Because GSK3β is a crucial autophagy regulator, inhibiting it increases autophagic activity, essential for removing toxic protein aggregates associated with neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease (Sun et al., 2016; Weikel et al., 2016). Here, GSK3B is linked to Huntington disease.